mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |